Endotoxin Testing

Overview

Endotoxin testing — formally the Bacterial Endotoxin Test (BET) — quantifies lipopolysaccharide (LPS) from Gram-negative bacteria. Even in a chemically pure peptide preparation, bacterial contamination during synthesis, purification, or formulation can leave behind endotoxin that persists through sterility testing and triggers fever, inflammation, or septic reactions in humans and animals.

Endotoxin testing is a mandatory release test for injectable pharmaceuticals. See the glossary entry on endotoxin for background biology.

Specifications

USP, EP, JP monographs

All pharmacopeia agree on the general test structure but differ on details. For parenteral peptides, typical endotoxin limits are:

• Injectable drugs: 5 EU/kg body weight per hour (USP <85>)
• Intrathecal products: 0.2 EU/kg/h (much stricter)
• Dialysis water: 0.25 EU/mL
• Water for injection: 0.25 EU/mL

Convert to per-unit-dose by multiplying by maximum human dose and safety factor.

Calculating maximum valid dilution (MVD)

MVD = (Endotoxin Limit × Concentration) / λ

where λ is the assay sensitivity. Testing must be done at a dilution ≤ MVD to achieve acceptable detection.

Assay Types

Gel-clot

The original LAL (Limulus Amebocyte Lysate) test:

1. Sample is mixed 1:1 with lysate and incubated at 37°C for 60 min
2. Tube inverted gently
3. A firm clot that remains in place when inverted = positive
4. Reading is semi-quantitative — pass/fail at the declared λ

Simple and robust; still widely used for release testing. Less sensitive than kinetic methods.

Turbidimetric (kinetic)

Measures clotting-associated turbidity increase over time. Time to a defined turbidity threshold is inversely related to endotoxin concentration.

• More sensitive than gel-clot
• Quantitative across a wide concentration range
• Requires plate reader and validated software

Chromogenic

Uses a synthetic substrate for clotting enzymes that releases p-nitroaniline upon cleavage, producing a yellow color measured at 405 nm.

• Excellent sensitivity (down to 0.005 EU/mL)
• Quantitative
• Colored or turbid samples can interfere; dilution or corrective measures needed

Recombinant factor C (rFC)

Replaces the horseshoe crab-derived LAL with recombinant Limulus factor C expressed in yeast or insect cells. Fluorescent readout.

• Animal-free — sustainable alternative to LAL
• Comparable sensitivity to chromogenic LAL
• Accepted by EP (ch. 2.6.32) since 2021 and by USP <86> since 2024
• Validation required to demonstrate equivalence when replacing traditional LAL

Procedure Overview (Chromogenic Example)

1. Prepare LAL or rFC reagent per manufacturer's instructions
2. Dilute peptide sample in endotoxin-free water to a point within the standard curve and below the MVD
3. Prepare endotoxin standard dilutions (typically 0.005, 0.01, 0.05, 0.1, 1 EU/mL)
4. Include positive product control (PPC) — sample spiked with known endotoxin
5. Include negative control (endotoxin-free water)
6. Add reagent, incubate at 37°C in a plate reader
7. Measure time to OD threshold or absorbance at endpoint
8. Fit standard curve (log-log) and interpolate sample values
9. PPC recovery must be within 50–200% of spike value; failures indicate interference

Interference Testing

Peptides can inhibit or enhance endotoxin detection. Validation requires:

• Spike a known endotoxin concentration into the product
• Compare recovery to water-spiked control
• Pass: 50–200% recovery
• Fail: investigate and resolve by dilution, pH adjustment, heat treatment, or chemical modification

Common Interferences

• Peptide-LPS binding — some amphipathic peptides sequester endotoxin, falsely lowering detection. Dilution often resolves this.
• pH outside 6.0–8.0 — neutralize before assay
• Divalent cations — chelators (EDTA) may help
• Nonionic surfactants (Tween) — some tolerated, some not
• Color/turbidity for chromogenic/turbidimetric — use appropriate assay or dilute

Sample Preparation

• Use depyrogenated glassware (250°C, 30 min)
• Use endotoxin-free water and plasticware (certified by manufacturer)
• Perform work under sterile technique conditions
• Avoid stainless steel, which can adsorb endotoxin

Reducing Endotoxin Contamination

• Source control — use endotoxin-free reagents, water, and consumables
• Ultrafiltration — 10 kDa cutoff membranes remove some LPS
• Affinity chromatography — polymyxin B columns bind LPS
• Depyrogenation — dry heat at 250°C for 30 min for glassware
• Detergent wash — Triton X-114 phase extraction for protein samples
• Ion exchange — anion exchange resins capture negatively charged LPS
• Limit manipulation — every transfer risks contamination

For peptide manufacturing, end-to-end controls during HPLC purification, lyophilization, and fill/finish minimize endotoxin load before final BET.

Documentation

A complete endotoxin test report includes:

• Lot and sample identity
• Test method and instrument
• Standard curve and goodness of fit
• Sample dilution(s) tested
• PPC recovery
• Calculated endotoxin level (EU/mg or EU/mL)
• Comparison to specification
• Operator signatures and dates

Combined with Sterility

Endotoxin and sterility testing are complementary. Endotoxin can be present even after sterilization (heat-stable LPS survives autoclaving). Always test for both before clinical or animal use.

Summary

Endotoxin testing confirms that a peptide product is not contaminated with pyrogenic bacterial lipopolysaccharide. Modern assays — kinetic chromogenic or recombinant factor C — provide quantitative results at sensitivity suitable for parenteral products. Combined with interference validation, robust sample preparation, and contamination-control strategies, BET is a cornerstone of peptide quality assurance.